事業提携・ライセンシング・投資・M&A動向(四半期別):Q2 2013...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q2 2013 15
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q2 2013 15
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q2 2013 18
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q2 2013 19
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q2 2013 20
2.4.1 Life Technologies Receives Shareholders Approval for Its Acquisition by Thermo Fisher Scientific for US$13.6 Billion 20
2.4.2 Valeant Pharma Completes Acquisition of Bausch & Lomb for US$ 8.7 Billion 22
2.4.3 Actavis Receives French Competition Authority Approval to Acquire Warner Chilcott for US$8.5 Billion 23
2.4.4 Merck Completes Public Offering of Notes for US$6.5 Billion 24
2.4.5 Tenet Healthcare to Acquire Vanguard Health Systems for US$4.3 Billion 25
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 26
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q2 2013 26
3.1.1 Top M&A Deals in Q2 2013 28
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q2 2012 – Q2 2013 29
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q2 2013 31
3.2.1 Top Initial Public Offerings in Q2 2013 32
3.2.2 Top Secondary Offerings in Q2 2013 32
3.2.3 Top PIPE Deals in Q2 2013 33
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q2 2012-Q2 2013 33
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q2 2012 – Q2 2013 34
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q2 2013 36
3.3.1 Top Venture Financing Deals in Q2 2013 37
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q2 2013 38
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q2 2013 39
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q2 2012 – Q2 2013 40
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Last Four Quarters 42
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 44
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q2 2013 45
3.4.1 Top Private Equity Deals in Q2 2013 46
3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q2 2012 – Q2 2013 47
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q2 2013 49
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q2 2013 49
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q2 2012 – Q2 2013 51
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2013 53
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q2 2013 54
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q2 2013 55
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q2 2013 56
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2012 – Q2 2013 57
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q2 2012 – Q2 2013 59
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q2 2012 – Q2 2013 60
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2012 – Q2 2013 62
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q2 2013 64
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q2 2013 64
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2012 – Q2 2013 66
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q2 2013 68
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q2 2013 68
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q2 2013 69
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q2 2012 – Q2 2013 70
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q2 2012 – Q2 2013 72
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q2 2012 – Q2 2013 74
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q2 2012 – Q2 2013 75
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q2 2012 – Q2 2013 77
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 79
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q2 2012 – Q2 2013 79
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q2 2012 – Q2 2013 81
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q2 2012 – Q2 2013 83
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q2 2012 – Q2 2013 85
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q2 2012 – Q2 2013 87
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q2 2012 – Q2 2013 89
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q2 2012 – Q2 2013 90
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 92
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q2 2013 92
7.1.1 Oncology – Deals of the Quarter 94
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q2 2013 96
7.2.1 Central Nervous System – Deals of the Quarter 98
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q2 2013 99
7.3.1 Infectious Disease – Deals of the Quarter 101
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q2 2013 103
7.4.1 Immunology – Deals of the Quarter 105
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q2 2013 106
7.5.1 Metabolic Disorders – Deals of the Quarter 108
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q2 2013 110
7.6.1 Cardiovascular – Deals of the Quarter 112
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q2 2013 114
7.7.1 Gastrointestinal – Deals of the Quarter 116
7.8 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q2 2013 117
7.8.1 Ophthalmology – Deals of the Quarter 119
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q2 2013 120
7.9.1 Respiratory – Deals of the Quarter 122
7.10 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q2 2013 124
7.10.1 Dermatology – Deals of the Quarter 126
8 Deal Summary by Geography 127
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q2 2013 127
8.1.1 North America – Deals of the Quarter 129
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q2 2013 132
8.2.1 Europe – Deals of the Quarter 134
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q2 2013 136
8.3.1 Asia-Pacific – Deals of the Quarter 138
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q2 2013 139
8.4.1 Rest of the World – Deals of the Quarter 141
9 Pharmaceuticals & Healthcare, Global, Top Advisors 143
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 143
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 145
10 Appendix 147
11 Further Information 151
11.1 Methodology 151
11.2 About GlobalData 152
11.3 Disclosure information 153
11.4 Disclaimer 153


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向(四半期別):Q2 2013
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013
■ 発行日:2013年8月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161917
■ 調査対象地域:グローバル
  • コネクテッドトイの世界市場予測(~2024年)
    Increasing adoption of educational toys among kids to drive the growth of the global connected toys market The global connected toys market is expected to grow from USD 5.7 billion in 2019 to USD 13.8 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 19.3% during the forecast period. It is driven by various factors, including the growing adoption of Science, Technology, Engineering, and …
  • 世界のヘルスケア産業におけるクラウドコンピューティング市場
    About Healthcare Cloud Computing Increased adoption of IT in healthcare has led to a rise in the adoption of cloud computing by the Global Healthcare industry. Though there are significant challenges such as high initial investment and shortage of skilled workforce, cloud computing is expected to witness a significant rise in its adoption by healthcare providers. There is also increased need for i …
  • ワークフロー管理のグローバル市場動向(2014-2019)
    Workflow management systems comprise information management, document management, automation of work procedures, comprehensive conceptualization, and model building of business operations. Workflow management solutions sequence and mechanize multifaceted business processes, and encourage business process reengineering. The emergence of mobile workforce and work from home culture, promotes workflow …
  • 硫酸ナトリウムの世界市場動向及び予測2015
    The present report is an essential resource for a one looking for detailed information on the world sodium sulphate market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true i …
  • メガデータセンターの世界市場2015-2019
    IT is now the backbone of every business, ensuring business continuity and competition, and it is prompting enterprises worldwide to invest in data centers. Technavio’s market research analysts predict the global data center market to surpass revenues over USD 14 billion until 2019. Digitalization is enabling many organizations to adopt cloud-based services for their businesses. By 2019, it is exp …
  • 拡張現実(AR)用スマートグラスの世界市場2015-2019
    About Mobile Augmented Reality Smart glasses are devices that are fitted with a small display and can also be used as conventional glasses. Smart glasses are a sleeker version of HMD and while the functioning of smart glasses is similar to HMDs, they also have a see-through display and look like a pair of normal glasses. The adoption of smart glasses is expected to increase significantly among ent …
  • ソフトウェア定義ストレージ(SDS)の世界市場2019-2023
    Global Software-defined Storage Market: About this market Software-defined storage enables enterprises to increase their storage capacity and offers simplified data management without depending on hardware. Technavio’s software-defined storage market analysis considers sales to the banking, financial services and insurance (BFSI), telecom and IT, government, healthcare, and other segments. Our ana …
  • 消化酵素サプリメントの世界市場分析:起源別(動物、植物、微生物)、用途別(追加サプリメント、医療・幼児栄養、スポーツ栄養)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、CSA、MEA)、セグメント予測、2014-2025
    The global digestive enzyme supplements market is expected to reach USD 1.6 billion by 2025, according to a new report published by Grand View Research, Inc. Growing consumer awareness regarding the severity of digestive disorders coupled with the need for good health is expected to stimulate industry growth over the forecast period. The increasing incidence of gastrointestinal tract diseases, suc …
  • 滅菌装置の世界市場:湿熱滅菌、乾熱滅菌、酸化エチレン滅菌、ろ過滅菌、電子線滅菌、ガンマ線滅菌
    The global sterilization equipment market is poised to reach USD 6,142.7 million by 2020 from USD 4,258.4 million in 2015, at a CAGR of 7.6%. The sterilization equipment market is segmented by type; consumables and accessories market, by type; contract sterilization services market, by site of sterilization; end user; and region. Consumables and accessories is an attractive segment of the steriliz …
  • 世界のスーパーマーケット/ディスカウントストア市場2014-2019:市場動態、ネット通販動向、競争状況
    Summary The “Global Hypermarkets, Supermarkets and Hard-Discounters, 2014-2019” report, published by Conlumino, provides analysis of current and forecast market data for retail sales in different category groups in the hypermarkets, supermarkets and hard-discounters retail channel across the globe. In addition, it highlights the fastest growing markets for hypermarkets, supermarkets and hard-disco …
  • 糖尿病性黄斑浮腫(Diabetic Macular Edema)の治療薬パイプライン動向(2015年上半期版)
    Diabetic Macular Edema - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Diabetic Macular Edema - Pipeline Review, H1 2015’, provides an overview of the Diabetic Macular Edema’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Macular Edema, complete with comparative analysis at various stages, therapeutics assessment by dr …
  • 世界の商用航空機市場動向2013-2023
    Why was the report written? “The Global Commercial Aircraft Market 2013-2023” offers the reader detailed analysis of the global commercial aircraft market over the next ten years, alongside potential market opportunities to enter the industry, using detailed market size forecasts. What are the key drivers behind recent market changes? The global commercial aircraft sector is expected to experience …
  • AEC(建築・工学・建設)ソリューションの世界市場2016-2020
    About the Architectural Engineering and Construction Market AEC solutions include both software and services for the construction of large and complex residential, industrial, and commercial buildings. It includes features such as designing, building, operations, and management. The major end-users of AEC solutions include architects, engineers, and contractors. There is widespread adoption of AEC …
  • Mycoplasma:医療検査市場2014
    The report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mycoplasma definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Co …
  • LEDバックライトDDIC(ディスプレイ用ドライバーIC)の世界市場
    LEDs are light sources that operate at a low voltage and require a constant DC voltage or current. To function efficiently, the light sources must be protected from line-voltage fluctuations. LED backlight DDICs provide these solutions for the backlighting unit (BLU). DDICs are a significant component of display devices, generating a video signal. LED backlight DDICs receive image data and deliver …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。